SMTL ID : 9c92.2 (1 other biounit)

Crystal structure of menin in complex with inhibitor compound 15

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x 01: N-ethyl-5-fluoro-2-[(5-{7-[(1-methylcyclopropyl)methyl]-2,7-diazaspiro[3.5]nonan-2-yl}-1,2,4-triazin-6-yl)oxy]-N-(propan-2-yl)benzamide

01.1: 17 residues within 4Å: Chain A: S.173, L.195, S.196, E.197, D.198, H.199, A.200, F.256, C.259, A.260, Y.294, M.296, N.300, Y.337, M.340, Y.341, E.381 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.195, A:F.256, A:A.260, A:Y.337, A:Y.337, A:M.340, A:Y.341 Hydrogen bonds: A:Y.294, A:N.300

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chapsal, B.D. et al., Design of Potent Menin-KMT2A Interaction Inhibitors with Improved In Vitro ADME Properties and Reduced hERG Affinity. Acs Med.Chem.Lett. (2024)

Release Date

2025-01-15

Peptides

Menin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Menin

Related Entries With Identical Sequence